v3.26.3
Balance Sheet Details
9 Months Ended
Sep. 30, 2026
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Details Balance Sheet Details
Cash, cash equivalents and restricted cash consist of the following:
September 30, 2026December 31, 2025
(in thousands)
Cash and cash equivalents$81,085 $72,806 
Short-term restricted cash1,359 1,419 
Long-term restricted cash27,420 27,187 
Total cash, cash equivalents and restricted cash$109,864 $101,412 
As of September 30, 2026 and December 31, 2025, cash and cash equivalents included money market funds of approximately $2.0 million and $19.2 million, respectively. As of September 30, 2026 and December 31, 2025, the Company had restricted cash of approximately $28.8 million and $28.6 million, respectively. The cash is restricted in connection with guarantees for certain import duties, office leases and purchase obligations.
Inventory consists of the following:
September 30, 2026December 31, 2025
(in thousands)
Work-in-process$79,013 $47,598 
Finished goods34,709 30,506 
$113,722 $78,104 
Property and equipment, net consists of the following:
Useful Life
(in Years)
September 30, 2026December 31, 2025
(in thousands)
Furniture and fixtures5$4,059 $4,006 
Machinery and equipment
3-5
92,420 87,043 
Masks and production equipment567,099 66,044 
Software311,290 11,498 
Leasehold improvements
1-5
35,425 35,632 
Construction in progressN/A2,168 2,516 
212,461 206,739 
Less: accumulated depreciation and amortization(171,185)(157,866)
$41,276 $48,873 
Depreciation expense for the three months ended September 30, 2026 and 2025 was $5.4 million and $5.7 million, respectively. Depreciation expense for the nine months ended September 30, 2026 and 2025 was $16.8 million and $17.4 million, respectively.
As of September 30, 2026, the Company held a note receivable from a supplier of $8.0 million with annual repayments of $2.0 million per year due annually by March 31, from 2027 through 2030, provided that certain production utilization targets are met. The long-term portion of the note receivable of $6.0 million is included in other long-term assets as of September 30, 2026 and December 31, 2025.
On January 5, 2026, the Company entered into a convertible note receivable of $2.0 million with a privately-held entity. The convertible note receivable bears interest at an annual rate of 3.87%, compounded annually. The note is due and payable at any time on or after the maturity date of January 5, 2029, unless earlier converted. The outstanding principal and any unpaid accrued interest are convertible into shares of the entity or repayable under certain conditions. Conversion occurs automatically upon the closing of the investee’s next equity financing of at least $10.0 million, provided the entity has achieved a specified milestone prior to such financing, or conversion may be elected by the Company under certain conditions. If the entity fails to achieve the milestone prior to the maturity date, the Company may, at any time on or after maturity, elect either repayment of the outstanding principal and accrued interest or conversion into shares of the entity. The convertible note receivable of $2.0 million is included in other long-term assets as of September 30, 2026.
The following table sets forth activity related to the accrued price protection liability:
Nine Months Ended September 30,
20262025
(in thousands)
Beginning balance$26,493 $43,401 
Charged as a reduction of revenue25,582 21,506 
Revisions to accrued rebates(4,667)(22,289)
Payments(17,041)(8,779)
Ending balance$30,367 $33,839 
Accrued expenses and other current liabilities consist of the following:
September 30, 2026December 31, 2025
(in thousands)
Accrued technology license payments$4,079 $3,687 
Accrued professional fees2,472 6,882 
Accrued engineering and production costs13,635 8,469 
Accrued restructuring2,659 13,390 
Short-term lease liabilities8,167 9,096 
Accrued customer credits8,453 6,398 
Income tax liability444 511 
Customer contract liabilities284 4,222 
Accrued obligations to customers for price adjustments14,428 11,922 
Accrued obligations to customers for stock rotation rights343 222 
Contingent consideration - current portion2,600 2,600 
Other6,911 4,993 
$64,475 $72,392 
The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:
Cumulative Translation AdjustmentsPension and Other Defined Benefit Plan ObligationTotal
(in thousands)
Balance at December 31, 2025$(327)$1,357 $1,030 
Other comprehensive loss before reclassifications, net of tax(389)— (389)
Balance at September 30, 2026$(716)$1,357 $641